Add to ORKGStatins are the first line treatment for hyperlipidemia. However, some patients do not tolerate statins. For these patients, alternative treatments such as red yeast rice may be considered. The purpose of this literature review is to compare the lipid lowering capability of red yeast rice to statins
Reducing low-density lipoprotein cholesterol (LDL-C) levels is a key target for lowering cardiovascu...
Efficacy of a new patented proprietary combination of natural nutraceuticals (PN) containing natural...
André Farkouh,1 Christoph Baumgärtel21Division of Clinical Pharmacy and Diagnostics, Dep...
Background: Hyperlipidemia is a very common condition as it affects millions of people globally. Wit...
Background: Dyslipidemia is major risk factor of non-communicable disease and nutraceutical like red...
Background: Red yeast rice is an herbal supplement that decreases low-density lipoprotein (LDL) chol...
Abstract Background: Dyslipidemia is major risk factor of non-communicable disease and nutraceutica...
To explore whether red yeast rice is a safe and effective alternative approach for dyslipidemia.Pubm...
<div><p>Objective</p><p>To explore whether red yeast rice is a safe and effective alternative approa...
Objective: The objective of this selective EBM review is to determine whether or not patients who ha...
Introduction: A relevant role is now emerging for nutraceuticals and specific functional foods in th...
The risk of atherosclerotic cardiovascular disease (ASCVD) is strongly related to lifetime exposure ...
• First line treatment of cardiovascular disease is lifestyle modification followed by the pharmacol...
1. Preamble : Hypercholesterolemia is a major risk factor for atherosclerotic cardiovascular disease...
Hypercholesterolemia, a risk factor for atherosclerosis and associated cardiovascular diseases is cu...
Reducing low-density lipoprotein cholesterol (LDL-C) levels is a key target for lowering cardiovascu...
Efficacy of a new patented proprietary combination of natural nutraceuticals (PN) containing natural...
André Farkouh,1 Christoph Baumgärtel21Division of Clinical Pharmacy and Diagnostics, Dep...
Background: Hyperlipidemia is a very common condition as it affects millions of people globally. Wit...
Background: Dyslipidemia is major risk factor of non-communicable disease and nutraceutical like red...
Background: Red yeast rice is an herbal supplement that decreases low-density lipoprotein (LDL) chol...
Abstract Background: Dyslipidemia is major risk factor of non-communicable disease and nutraceutica...
To explore whether red yeast rice is a safe and effective alternative approach for dyslipidemia.Pubm...
<div><p>Objective</p><p>To explore whether red yeast rice is a safe and effective alternative approa...
Objective: The objective of this selective EBM review is to determine whether or not patients who ha...
Introduction: A relevant role is now emerging for nutraceuticals and specific functional foods in th...
The risk of atherosclerotic cardiovascular disease (ASCVD) is strongly related to lifetime exposure ...
• First line treatment of cardiovascular disease is lifestyle modification followed by the pharmacol...
1. Preamble : Hypercholesterolemia is a major risk factor for atherosclerotic cardiovascular disease...
Hypercholesterolemia, a risk factor for atherosclerosis and associated cardiovascular diseases is cu...
Reducing low-density lipoprotein cholesterol (LDL-C) levels is a key target for lowering cardiovascu...
Efficacy of a new patented proprietary combination of natural nutraceuticals (PN) containing natural...
André Farkouh,1 Christoph Baumgärtel21Division of Clinical Pharmacy and Diagnostics, Dep...